News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Arndt Vogel: Efficacy of zanidatamab in HER2 positive advanced biliary tract cancers
Arndt Vogel/X
Apr 20, 2025, 09:11

Arndt Vogel: Efficacy of zanidatamab in HER2 positive advanced biliary tract cancers

Arndt Vogel, Managing Senior Consultant and a Professor in the Department of Gastroenterology, Hepatology, and Endocrinology at Hannover Medical School, shared an article by Cristina Smolenschi, et al. on X:

“Real-world efficacy of zanidatamab in HER2 positive advanced biliary tract cancers.

  • RWD.
  • ORR 40%, DCR 65%.
  • mPFS 6.7mo, 1-yr OS 80%.
  • Higher efficacy in 3+ vs 2+.
  • Confirmed benefit for Zanidatamab.”

Arndt Vogel: Efficacy of zanidatamab in HER2 positive advanced biliary tract cancers

Real-world efficacy of zanidatamab in patients with HER2 positive advanced biliary tract cancers.

Authors: Cristina Smolenschi, et al.

Arndt Vogel: Efficacy of zanidatamab in HER2 positive advanced biliary tract cancers

Arndt Vogel Biliary tract cancers cancer 𝐄𝐧𝐝𝐨𝐜𝐫𝐢𝐧𝐨𝐥𝐨𝐠𝐲 fight against cancer Gastroenterology Global fight against cancer Hannover Medical School Hepatology HER2-positive OncoDaily Oncology Zanidatamab
Special Coverage
Blog
Apr 20, 2025, 12:54
The invitation to the 6th Annual Meeting in Budapest is waiting for you - SIOP Europe
Blog
Apr 20, 2025, 12:40
Small Cell SMASHERS series highlights the latest discoveries and breakthroughs for SCLC - LUNGevity Foundation
Science
Apr 20, 2025, 12:33
Naveen Pemmaraju: Idarubicin and Cytarabine for patients with relapsed and/or refractory AML
Blog
Apr 20, 2025, 12:23
Proud to have over 70 Cardio-Oncology Centers of Excellence around the world - International Cardio-Oncology Society
Blog
Apr 20, 2025, 12:18
Every child deserves a safe, welcoming space during cancer treatment - Childhood Cancer International
Blog
Apr 20, 2025, 12:15
Hidehito HORINOUCHI: Honored to have been nominated for IASLC 2025 Board of Directors Election
Societies
Apr 20, 2025, 12:10
Where to Study to Become ASCO President: 2025 Institutional Rankings
Blog
Apr 20, 2025, 12:03
NCODA - HealthWell Foundation has opened a fund to support individuals living with NETs
Blog
Apr 20, 2025, 12:02
Himil Mahadevia: Humbled to receive the 2025 Conquer Cancer Merit Award for our study on CART outcomes
Blog
Apr 20, 2025, 11:57
David Zaas: Inspiring day with the team at Atrium Health Wake Forest Baptist Wilkes Medical Center
Blog
Apr 20, 2025, 11:55
ESMO Fellowship applications are now open!
Blog
Apr 20, 2025, 11:55
Petros Grivas: Support to our fundraising effort for bladder cancer